Why invest
in BioNeutra Global Corporation?

BioNeutra Global Corporation (TSX.V: BGA) researches, develops and commercializes food ingredients for nutraceutical and mainstream food products. It is the only health ingredient manufacturer in Canada to leverage science-based processes into the commercial product marketplace. BioNeutra is a leader in IMO technology and VitaFiber™ IMO is recognized in Canada, USA. Europe, Australia and New Zealand. With the prebiotics industry at an emerging stage and revenue growth expected at 25% per year, BioNeutra can deliver significant shareholder value in this health super cycle. Here are a few additional reasons to invest in BGA:

• Strong growth in revenue and cash flow
• Recent acquisition of production facility to ensure quality control
• Product leadership growing global demand
• Management team who can execute

So contact us today to learn more about the unique investment opportunity with BioNeutra.

For further information, please click on the following links; 

BioNeutra 2019 Company Report

BioNeutra Global Corporation 2019 Report

BioNeutra Global Corporation Annual Report 2016

BioNeutra-Factsheet-Spring 2017


For investor relations inquiries, please contact:

Bill Smith
Senior Vice President
BioNeutra North America Inc.
9608 25th AVE NW, Edmonton, Alberta T6N 1J4, Canada
Tel: 1.587.414.5070   Ext. 117

We research, develop, produce and commercialize ingredients for nutraceutical, functional and mainstream foods and beverages


9608 25 Avenue NW
Edmonton, Alberta T6N 1J4
Tel: 1.780.466.1481
Fax: 1.780.801.0036

©2020 BioNeutra